The Emergence of Artificial Intelligence in Drug Discovery
Over the past decade, artificial intelligence has made tremendous strides across various industries by automating tasks and augmenting human capabilities. The life sciences sector has also begun to leverage AI technologies to tackle complex challenges surrounding drug discovery and development. Faced with increasingly high costs, long development cycles, and low success rates, pharmaceutical companies have turned to AI as a way to streamline the drug discovery process.
Machine Learning Artificial Intelligence in Drug Discovery
One of the primary applications of Artificial Intelligence in Drug Discovery is in compound screening - the process of experimentally testing thousands to millions of chemical compounds to identify potential drug candidates. Machine learning algorithms can analyze large databases of chemical structures and their biological activities to identify molecular features that make a compound more likely to successfully interact with a target linked to a disease. These computational models are then applied to virtually screen entire libraries of compounds to narrow down the most promising options for further lab testing. By prioritizing the most biologically relevant molecules, machine learning enables researchers to maximize their experimental throughput and accelerate the discovery of potential new drugs. Several biotech startups focused on compound screening have also emerged to offer ML-as-a-service solutions to pharmaceutical companies.
Get More Insights on- Artificial Intelligence in Drug Discovery
Explore More Related Article On-Molybdenum Market
